Shree Ganesh Biotech (India) (BOM:539470) ROCE %: -0.94% (As of Mar. 2026)

What is Shree Ganesh Biotech (India) ROCE %?

Shree Ganesh Biotech (India) BOM:539470 53 ROCE % is -0.94% as of Mar. 2026. GuruFocus rates BOM:539470 with a GF Score™ of 53/100 and a GF Value™ of ₹0.20 (Significantly Overvalued). The stock has 2 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Shree Ganesh Biotech (India)'s annualized ROCE % for the quarter that ended in Mar. 2026 was -0.94%.

Shree Ganesh Biotech (India) (BOM:539470) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Shree Ganesh Biotech (India) ROCE % Related Terms

Shree Ganesh Biotech (India) ROCE % Historical Data

* Premium members only.

The historical data trend for Shree Ganesh Biotech (India)'s ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shree Ganesh Biotech (India) ROCE % Chart

Shree Ganesh Biotech (India) Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Mar26

ROCE %

Get a 7-Day Free Trial

5.92

4.43

1.36

0.61

0.81

Shree Ganesh Biotech (India) Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
ROCE %	Get a 7-Day Free Trial															-5.98	2.07	0.09	2.03	-0.94

53GF Score

Shree Ganesh Biotech (India) Ltd BOM:539470

ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Shree Ganesh Biotech (India) ROCE % Calculation

Shree Ganesh Biotech (India)'s annualized ROCE % for the fiscal year that ended in Mar. 2026 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Mar. 2026 )		(A: Mar. 2025 )		(A: Mar. 2026 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Mar. 2026 )		(A: Mar. 2025 )		(A: Mar. 2026 )
	=	5.141	/	( ( (634.876 - 2.317)	+	(638.029 - 1.695) )	/ 2 )
	=	5.141	/	( (632.559	+	636.334)	/ 2 )
	=	5.141	/	634.4465
	=	0.81 %

Shree Ganesh Biotech (India)'s ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2026 )		(Q: Dec. 2025 )		(Q: Mar. 2026 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2026 )		(Q: Dec. 2025 )		(Q: Mar. 2026 )
	=	-5.972	/	( ( (0 - 0)	+	(638.029 - 1.695) )	/ 1 )
	=	-5.972	/	( ( 0	+	636.334 )	/ 1 )
	=	-5.972	/	636.334
	=	-0.94 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

Frequently Asked Questions Learn more about ROCE % →

What does a ROCE % of -0.94% mean?

Shree Ganesh Biotech (India) (BOM:539470) has a ROCE % of -0.94% as of Mar. 2026.

Is Shree Ganesh Biotech (India)'s ROCE % too high?

Shree Ganesh Biotech (India)'s current ROCE % is -0.94%. Overall, Shree Ganesh Biotech (India) has a GF Score™ of 53/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.

How does Shree Ganesh Biotech (India)'s ROCE % compare to CTVA and CF?

Shree Ganesh Biotech (India)'s ROCE % of -0.94% can be compared against companies in the Agriculture industry. The industry median ROCE % is 9.49. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good ROCE % for an Agriculture company?

The median ROCE % among Agriculture companies is 9.49, based on 252 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high ROCE % mean?

A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Agriculture industry, the median ROCE % is 9.49 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shree Ganesh Biotech (India)'s current ROCE % is -0.94%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Shree Ganesh Biotech (India) stock overvalued right now?

Based on GuruFocus' analysis, Shree Ganesh Biotech (India) (BOM:539470) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹0.20, compared to a current price of ₹0.56 — trading 180% above its estimated fair value. The current ROCE % is -0.94%. Shree Ganesh Biotech (India)'s overall GF Score™ is 53/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is ROCE % calculated?

ROCE % is calculated from a company's financial statements. For Shree Ganesh Biotech (India) (BOM:539470), the current ROCE % is -0.94% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shree Ganesh Biotech (India) (BOM:539470) Overvalued in 2026?

Based on GuruFocus' analysis, Shree Ganesh Biotech (India) stock appears to be overvalued. The current stock price of ₹0.56 is trading 180% above its estimated GF Value™ of ₹0.20. GuruFocus considers Shree Ganesh Biotech (India) to be Significantly Overvalued.

Key valuation signals for BOM:539470:

ROCE %: -0.94%
GF Value™: ₹0.20 vs. price of ₹0.56 (180% above fair value)
GF Score™: 53/100 with 2 warning signs

No single metric tells the full story. See the BOM:539470 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Shree Ganesh Biotech (India) Business Description

Industry Basic Materials Agriculture

Comparable Companies BOM:540190 NSE:BOHRAIND NSE:CONTI BOM:526431 NSE:NIRMAN BOM:524808 BOM:543310 BOM:543516 BOM:512415 BOM:530433 CTVA TSX:NTR SZSE:000792 DSMD:IQCD CF SAU:2020 OSL:YAR AMM:JOPH SHSE:600096 MOS

Address Cubicle No.:126,3/2 ,75C,Park Street, 3rd Floor, Kamdhenu Building, Kolkata, WB, IND, 700016

Website http://www.shreeganeshbiotech.club

Shree Ganesh Biotech (India) Ltd is an India-based company mainly engaged in the business of production, processing and marketing of high-quality hybrid seeds for different crops like corn, sunflower, cotton, paddy, grain sorghum, etc.

53GF Score

Get the complete analysis for BOM:539470

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹0.56

Price

₹0.20

GF Value

View BOM:539470 Analysis

See ROCE % data for all stocks →